Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluarix/Influsplit SSW or Pandemrix booster study in adults previously vaccinated with Pandemrix
2010-020313-81Phase 3Terminated
- Sponsor
- GSK
- Start
- Jun 2010
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in influenza comparing Fluarix/Influsplit SSW 2010/2011 with Pandemrix (2 arms). Primary endpoints: Humoral immune response by haemagglutination inhibition antibodies and Safety and reactogenicity. Started Jun 2010; status: terminated.
02
Drugs
FluarixInfluenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated)
03
Conditions
influenza
Beyond the preview
Go deeper on 2010-020313-81.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020313-81.